Economic burden of acute myeloid leukemia: a literature review
- 31 May 2004
- journal article
- research article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 30 (3), 237-247
- https://doi.org/10.1016/j.ctrv.2003.11.002
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Outcomes and Costs of Acute Myeloid Leukemia Among the ElderlyArchives of Internal Medicine, 2002
- Costs of Diagnosis, Treatment, and Follow Up of Patients with Acute Myeloid Leukemia in the NetherlandsJournal of Hematotherapy & Stem Cell Research, 2001
- Outpatient Supportive Care Following Chemotherapy for Acute Myeloblastic LeukemiaLeukemia & Lymphoma, 2001
- Cost‐effectiveness and quality‐of‐life assessment of GM‐CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemiaBritish Journal of Haematology, 1998
- Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971-1988Cancer, 1997
- Cost analysis of different phases of acute myeloid leukaemiaLeukemia Research, 1994
- Costs over time in conventional treatment of acute myeloid leukaemia: A study exploring changes in treatment strategies over two decadesJournal of Internal Medicine, 1994
- Quality of life of patients with acute myeloid leukaemiaLeukemia Research, 1994
- The Economic Costs of Acute Myeloid Leukemia in SwedenInternational Journal of Technology Assessment in Health Care, 1994
- Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes.BMJ, 1991